Impact of Workplace Wellness-Program Participation on Medication Adherence

16 Pages Posted: 30 Jan 2016

See all articles by Paul Fronstin

Paul Fronstin

Employee Benefit Research Institute (EBRI)

M. Christopher Roebuck

RxEconomics LLC

Date Written: January 1, 2016

Abstract

This paper represents the third in a series that analyzes data from a large employer, which enhanced financial incentives to encourage participation in its workplace wellness programs. As in the two prior papers, study data came from a large manufacturer based in the Midwest, but with employees located throughout the U.S. Health insurance eligibility information, medical and prescription-drug claims, as well as wellness-program-participation data were obtained for the time period 2011-2013. The study sample included 71,982 full-time active employees, 18-64 years old (as of Dec. 31, 2013), and continuously enrolled in the employer’s health plan from 2011 through 2013. The employer had offered health risk assessments (HRAs) since at least 2004 and implemented biometric screenings in 2007. Individuals’ responses to HRAs and results of biometric screenings were also obtained. This paper estimates the effect of wellness-program participation on medication adherence in six chronic conditions: hypertension, dyslipidemia, diabetes, congestive heart failure, asthma/chronic obstructive pulmonary diseases, and depression. Biometric screenings led to an average increase in medication adherence for dyslipidemia and depression. Biometric screenings had no impact on medication adherence among individuals with hypertension, congestive heart failure, or asthma/chronic obstructive pulmonary diseases. Participation in HRAs had no statistically significant effects on medication adherence for any of the chronic conditions examined. Improvements in medication adherence may signal forthcoming medical-cost offsets and productivity enhancements from biometric screenings. Whether or not these benefits exceed program costs is a research question worthy of future study using data on a greater number of wellness programs, over longer time periods.

Note: The PDF for the above title, published in the January 2016 issue of EBRI Notes, also contains the full text of another January 2016 EBRI Notes article abstracted on SSRN: “Differences in Out-of-Pocket Health Care Expenses of Older Single and Couple Households.”

Keywords: Biometric screenings, Employment-based benefits, Financial incentives, Health insurance coverage, Health risk assessments (HRAs), Medication adherence, Prescription drug use, Wellness programs

JEL Classification: I1, I18, J3, J32

Suggested Citation

Fronstin, Paul and Roebuck, M. Christopher, Impact of Workplace Wellness-Program Participation on Medication Adherence (January 1, 2016). EBRI Notes, Vol. 37, No. 1 (January 2016), Available at SSRN: https://ssrn.com/abstract=2723584

Paul Fronstin (Contact Author)

Employee Benefit Research Institute (EBRI) ( email )

901 D St., SW
Suite 802
Washington, DC 20024
United States
202-775-6352 (Phone)
202-775-6312 (Fax)

M. Christopher Roebuck

RxEconomics LLC ( email )

11350 McCormick Road
Executive Plaza II, Suite 705
Hunt Valley, MD 21031
United States
410-215-8380 (Phone)
410-696-5802 (Fax)

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
71
Abstract Views
470
Rank
589,475
PlumX Metrics